Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL4266595

Fc1ccccc1Oc1ccccc1.N

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP10 Q53GL7 1/20 0.56
LTA4H P09960 1/20 0.50
TSHR P16473 1/20 0.50
SLC6A4 P31645 3/20 0.49
SLC6A2 P23975 3/20 0.49
HTR1A P08908 2/20 0.49
SLC6A3 Q01959 2/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
FAAH O00519 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
HRH1 P35367 1/20 0.48
CXCL8 P10145 1/20 0.47
KMT2A Q03164 2/20 0.47
LMNA P02545 1/20 0.47
GAA P10253 1/20 0.47
LPAR1 Q92633 1/20 0.45
LPAR5 Q9H1C0 1/20 0.45
CTNNB1 P35222 1/20 0.44
HTR2A P28223 1/20 0.43
ALDH1A1 P00352 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL702582 0.98 PARP10 (0.58) PARP10LTA4HTSHRSLC6A4SLC6A2
SCHEMBL6293051 0.90 PARP10 (0.66) PARP10SLC6A4SLC6A2HTR1ASLC6A3
SCHEMBL6289863 0.88 PARP10 (0.63) PARP10SLC6A2HTR1ASLC6A3L3MBTL1
SCHEMBL2458461 0.86 PARP10 (0.61) PARP10SLC6A4SLC6A2HTR1ASLC6A3
SCHEMBL6293879 0.86 PARP10 (0.61) PARP10SLC6A4SLC6A2HTR1ASLC6A3
SCHEMBL6290343 0.86 PARP10 (0.61) PARP10SLC6A4SLC6A2HTR1ASLC6A3
SCHEMBL6293904 0.86 PARP10 (0.61) PARP10SLC6A4SLC6A2HTR1ASLC6A3
SCHEMBL6290746 0.84 PARP10 (0.59) PARP10LTA4HTSHRSLC6A4SLC6A2
SCHEMBL6290371 0.84 PARP10 (0.59) PARP10LTA4HTSHRSLC6A4SLC6A2
SCHEMBL6290619 0.84 PARP10 (0.50) PARP10SLC6A4SLC6A2HTR1ASLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7579356-B2 Thia-tetraazaacenaphthylene kinase inhibitors JANSSEN PHARMACEUTICA NV (BE) 2009-08-25 US disclosed
US-20070265264-A1 5-(3-chloro-4-fluoro-phenyl)-4-oxo-4,5-dihydro-3H-1-thia-3,5,6,8-tetraaza-acenaphthylene-2-carboxylic acid (3,4-dimethoxy-phenyl)-amide JANSSEN PHARMACEUTICA, N.V. (BE) 2007-11-15 US disclosed
WO-2006118749-A1 THIA-TETRAAZAACENAPHTHYLENE KINASE INHIBITORS JANSSEN PHARMACEUTICA, N.V. (BE) 2006-11-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070265264-A1 5-(3-chloro-4-fluoro-phenyl)-4-oxo-4,5-dihydro-3H-1-thia-3,5,6,8-tetraaza-acenaphthylene-2-carboxylic acid (3,4-dimethoxy-phenyl)-amide ADK, MAP3K9, MAP4K5 PARP10 2500/4885LTA4H 1802/4885TSHR 2984/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.